A former top official at the National Institute of Allergy and Infectious Diseases has pleaded guilty to charges related to concealing records from Freedom of Information Act requests.
Eyepoint's experimental treatment for age-related blindness fails to meet primary goal, while Amylyx's Avexitide shows promise.
Eyepoint's experimental treatment for age-related blindness fails to meet primary goal in Phase 3 clinical trial.
Both the U.S. and U.K. health systems prioritize clinical interventions over community-based prevention, despite rising chronic illness and loneliness. A shift toward social infrastructure and community empowerment could reduce strain on hospitals and improve public health outcomes.